SENS250117P2000
- 1.10
- -0.25-18.52%
Senseonics Newsroom
Stifel Maintains Senseonics(SENS.US) With Buy Rating, Maintains Target Price $2.5
Stifel Nicolaus Keeps Their Buy Rating on Senseonics Holdings (SENS)
BTIG Maintains Senseonics(SENS.US) With Hold Rating
Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS) and Centessa Pharmaceuticals (CNTA)
HC Wainwright & Co. Reiterates Buy on Senseonics Holdings, Maintains $2 Price Target
Senseonics Holdings Analyst Ratings
BTIG Maintains Senseonics(SENS.US) With Hold Rating
BTIG Maintains Senseonics(SENS.US) With Hold Rating
HC Wainwright & Co. Reiterates Buy on Senseonics Holdings, Maintains $2 Price Target
Senseonics Holdings Analyst Ratings
Analysts Conflicted on These Healthcare Names: Senseonics Holdings (SENS), PepGen Inc. (PEPG) and 4D Molecular Therapeutics (FDMT)
Stifel Nicolaus Keeps Their Buy Rating on Senseonics Holdings (SENS)
Senseonics Holdings Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Trevena (TRVN), MoonLake Immunotherapeutics (MLTX) and Senseonics Holdings (SENS)
Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS), Azitra Inc (AZTR) and Dexcom (DXCM)
Senseonics Holdings (SENS) Receives a Hold From BTIG
Stifel Nicolaus Reaffirms Their Buy Rating on Senseonics Holdings (SENS)
BTIG Sticks to Their Hold Rating for Senseonics Holdings (SENS)
Senseonics Holdings (SENS) Receives a Hold From BTIG
Senseonics Holdings (SENS) Receives Buy Rating: Growth Factors, Successful Commercialization, and Optimistic Forecast Highlighted